$1.74
0.16.10%
Last update: 11:21 AM
15 minutes delayed
Comments
Loading...
Lexicon Pharmaceuticals (LXRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLexicon Pharmaceuticals (NASDAQ:LXRX) Stock Quotes, Forecast and News Summary
Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
| Open | $1.70 |
| Close | - |
| Volume / Avg. | 844.94K / 2.83M |
| Day Range | $1.65 - $1.74 |
| 52 Wk Range | 0.92 - 3.73 |
| Market Cap | $629.00M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 15.58% |
| Days to Cover | 8.64 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Lexicon Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, developm...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lexicon Pharmaceuticals (LXRX) stock?
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Who are Lexicon Pharmaceuticals (LXRX) competitors?
Other companies in Lexicon Pharmaceuticals’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT), Pharming (NASDAQ:PHAR) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Lexicon Pharmaceuticals (LXRX) stock?
Lexicon Pharmaceuticals has a consensus price target of $7.20.
What is the current price for Lexicon Pharmaceuticals (LXRX)?
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.74 last updated September 19, 2024 at 11:21 AM EDT.
Does Lexicon Pharmaceuticals (LXRX) pay a dividend?
There are no upcoming dividends for Lexicon Pharmaceuticals.
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Lexicon Pharmaceuticals (LXRX) going to split?
There is no upcoming split for Lexicon Pharmaceuticals.
What sector and industry does Lexicon Pharmaceuticals (LXRX) operate in?
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.